序号(S/N) | 时间/Date | 题目/Topic | 讲者/Speaker | 单位/Institution | ||
---|---|---|---|---|---|---|
1 | 08:05-08:20 |
Application of PARP inhibitor in AR variant positive CRPC |
|
|||
2 | 08:20-08:35 |
Pathology and treatment of CRPC |
|
|||
3 | 08:35-08:50 |
Modelling and Targeting CRPC or NEPC progression from Hormone-Naïve Prostate Cancer |
|
|||
4 | 08:50-09:05 |
iTind A New Comer of Minimally Invasive Surgery for BPH |
|
|||
5 | 09:05-09:10 |
Discussion |